The Results Are In!
A parallel arm clinical study was conducted evaluating ACUVUE® VITA® and Total30® for subjective COMFORT, VISION and HANDLING*,†,1.
See how ACUVUE® VITA® stacks up in overall comfort, vision, and handling.
* As measured on a 5-point Likert scale for satisfaction (Very Satisfied/Satisfied), agreement (Strongly Agree/Agree or Agree Strongly/Agree Somewhat), or performance (Excellent/Very Good)
† Descriptive summaries derived from a parallel group feasibility clinical study (ACUVUE® VITA®: n=83, TOTAL30®: n=83) intent to treat subjects, all subjects were screened for some experience of ‘glare’.
References:
1. JJV Data on file 2024, Descriptive Subjective Vision and Comfort Claims for ACUVUE® VITA® Contact Lenses.
2. JJV Data on file 2022. HydraMax® Technology Definition
3. JJV Data on File 2016. 30-day dispensing evaluation, monthly replacement DW study, n = 533 soft silicone hydrogel CL wearers in the U.S.
Important Safety Information: ACUVUE® VITA® Contact Lenses are indicated for vision correction as a daily wear lens with one-month recommended replacement. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. Consult the package insert for complete information. Complete information is also available from Johnson & Johnson Vision Care, Inc. by calling 1-800-843-2020, or by visiting www.jnjvisionpro.com.
Third-party trademarks used herein are the property of their respective owners.
© Johnson & Johnson and its affiliates 2024
2024PP17469
